![]() |
市場調查報告書
商品編碼
1494905
到 2030 年 D-胺基酸市場預測:按類型、製造方法、形式、應用、最終用戶和地區進行的全球分析D-Amino Acid Market Forecasts to 2030 - Global Analysis By Type, Production Method, Form, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球 D-氨基酸市場規模為 1.869 億美元,預計在預測期內將以 5.2% 的複合年成長率成長,並在 2030 年達到 2.547 億美元。
D-胺基酸是天然存在的L-胺基酸的鏡像形式,並以其分子結構的D-構型來區分。 L-胺基酸主要存在於蛋白質中,而 D-胺基酸在各種生物過程中具有獨特的作用,並用於藥物、食品添加劑和工業應用。 D-胺基酸在藥物穩定性和活性方面具有獨特的優勢,有助於其在生物技術和醫學中的專業應用。
根據歐洲製藥協會聯合會(EFPIA)統計,2020年歐洲藥品總產量為3,100億歐元(約3,540.8076億美元),較2019年成長5.7%。
增加食品和飼料添加劑的使用
食品和飼料添加劑對 D-氨基酸的需求不斷增加是市場的關鍵促進因素。 D-胺基酸用作風味增強劑、營養食品和飼料添加劑,以改善動物健康和生長。消費者對天然和健康食品的偏好不斷提高,加上對動物性產品的需求不斷成長,正在推動 D-氨基酸在這些應用中的使用,從而推動市場成長。
生產成本高
D-胺基酸的高生產成本是市場的主要限制因素。製造過程涉及複雜的酶反應和精製步驟,這導致成本上升。此外,原料供應有限以及對專業設備和熟練勞動力的需求進一步增加了生產成本。這些高成本可能會限制 D-氨基酸在價格敏感的應用和市場中的採用。
生物技術的進步
基因工程、酵素技術和發酵製程的進步使得 D-胺基酸的生產更有效率且更具成本效益。這些技術進步可以最佳化微生物菌株,提高產量和純度,並探索替代原料。生物技術創新有助於克服生產挑戰並擴大 D-氨基酸的應用範圍。
來自合成替代品的競爭
D-胺基酸市場面臨合成替代品的威脅。模仿 D-胺基酸特性和功能的合成化合物正在成為有競爭力的替代品。這些合成替代品可能具有生產成本較低、品質穩定和易於擴充性等優點。合成替代品的供應和採用的增加可能會影響對天然 D-氨基酸的需求,並對市場成長構成威脅。
COVID-19 大流行對 D-氨基酸市場產生了各種影響。食品和飼料行業對 D-氨基酸的需求因供應鏈挑戰和消費者支出減少而受到干擾,同時人們對含有 D-氨基酸的膳食食品等健康和保健產品的興趣也有所增加。然而,疫情期間經濟放緩以及製造業和貿易活動受到限制,為市場成長帶來了挑戰。
D-丙胺酸部分預計在預測期內將是最大的
在預測期內,D-丙胺酸部分預計將成為 D-胺基酸市場最大的部分。這是由於其在各行業的廣泛應用。 D-丙胺酸廣泛應用於食品工業中作為增味劑、改善動物營養的飼料添加劑,以及製藥工業中作為勝胜肽合成的基礎材料。 D-丙胺酸因其多功能性和這些關鍵應用領域不斷成長的需求而佔據市場主導地位。
預計食品產業在預測期內複合年成長率最高
預計在預測期內,食品領域將在 D-胺基酸市場中表現出最高的複合年成長率。消費者健康意識的提高,加上與文明病盛行率的上升,正在推動對營養食品的需求。 D-胺基酸擴大被納入營養食品中,因為它們具有潛在的健康益處,包括改善認知功能和肌肉恢復。食品產業的高成長潛力以及D-胺基酸在該領域的不斷擴大的應用預計將支持該領域的快速成長。
預計北美將佔據 D-氨基酸市場的最大佔有率。該地區的優勢可歸因於多種因素,包括成熟的食品和製藥行業、消費者對健康和營養的高度認知以及支持性的法規環境。尤其是美國,受機能性食品、營養食品和先進藥物配方需求的推動,成為 D-氨基酸的主要市場。該地區強大的研發能力和生物技術的技術進步也促成了其在D-氨基酸市場的主導地位。
預計亞太地區在預測期內 D-胺基酸市場的複合年成長率最高。該地區的成長是由可支配收入增加、飲食偏好變化以及消費者健康意識增強等因素所推動的。中國、日本和印度等國家由於人口眾多、食品和飼料工業不斷擴大以及對食品的需求不斷增加,對市場成長做出了重大貢獻。該地區研發投資的增加,加上先進生物技術的採用,預計將進一步推動亞太地區 D-氨基酸市場的快速成長。
According to Stratistics MRC, the Global D-Amino Acid Market is accounted for $186.9 million in 2024 and is expected to reach $254.7 million by 2030 growing at a CAGR of 5.2% during the forecast period. D-amino acids are the mirror-image forms of naturally occurring L-amino acids, distinguished by their D-configuration in the molecular structure. While L-amino acids are predominantly found in proteins, D-amino acids have unique roles in various biological processes and are utilized in pharmaceuticals, food additives, and industrial applications. They offer distinct advantages in drug stability and activity, contributing to their specialized use in biotechnology and medicine.
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), in 2020, the total production of pharmaceuticals in Europe was EURO 310,000 million (approximately US$354,080.76 million), an increase of 5.7% over 2019
Increasing use in food and feed additives
The growing demand for D-amino acids in food and feed additives is a significant driver for the market. D-amino acids are used as flavor enhancers, nutritional supplements, and feed additives to improve animal health and growth. The increasing consumer preference for natural and healthy food products, coupled with the rising demand for animal-based products, is fueling the use of D-amino acids in these applications, thereby driving market growth.
High production costs
The high production costs associated with D-amino acids are a major restraint for the market. The manufacturing process involves complex enzymatic reactions and purification steps, which contribute to the elevated costs. Additionally, the limited availability of raw materials and the need for specialized equipment and skilled labor further increase production expenses. These high costs can limit the adoption of D-amino acids in price-sensitive applications and markets.
Advancements in biotechnology
Developments in genetic engineering, enzyme technology, and fermentation processes are enabling more efficient and cost-effective production of D-amino acids. These technological advancements allow for the optimization of microbial strains, improvement of yield and purity, and the exploration of alternative raw materials. Biotechnology innovations can help overcome production challenges and expand the application scope of D-amino acids.
Competition from synthetic alternatives
The D-amino acid market faces a threat from synthetic alternatives. Synthetic compounds that mimic the properties and functions of D-amino acids are emerging as competitive substitutes. These synthetic alternatives may offer advantages such as lower production costs, consistent quality, and easier scalability. The increasing availability and adoption of synthetic alternatives can potentially impact the demand for natural D-amino acids and pose a threat to market growth.
The Covid-19 pandemic has had a mixed impact on the D-amino acid market. While the demand for D-amino acids in the food and feed industries experienced some disruptions due to supply chain challenges and reduced consumer spending, the market also witnessed increased interest in health and wellness products, including nutritional supplements containing D-amino acids. However, the pandemic-induced economic slowdown and restrictions on manufacturing and trade activities posed challenges for market growth during this period.
The D-Alanine segment is expected to be the largest during the forecast period
The D-Alanine segment is projected to be the largest segment in the D-amino acid market during the forecast period. This can be attributed to its wide range of applications in various industries. D-Alanine is extensively used as a flavor enhancer in the food industry, as a feed additive to improve animal nutrition, and as a building block for peptide synthesis in the pharmaceutical industry. The versatility and increasing demand for D-Alanine across these key application areas contribute to its dominant market position.
The nutritional supplements segment is expected to have the highest CAGR during the forecast period
The nutritional supplements segment is anticipated to exhibit the highest CAGR in the D-amino acid market during the forecast period. The growing consumer awareness about health and wellness, coupled with the rising prevalence of lifestyle-related diseases, is driving the demand for nutritional supplements. D-amino acids are increasingly being incorporated into dietary supplements due to their potential health benefits, such as improved cognitive function and muscle recovery. The high growth potential of the nutritional supplements industry and the expanding application of D-amino acids in this segment are expected to fuel its rapid growth.
North America is expected to hold the largest share in the D-amino acid market. The region's dominance can be attributed to several factors, including the presence of well-established food and pharmaceutical industries, high consumer awareness about health and nutrition, and supportive regulatory environment. The United States, in particular, is a major market for D-amino acids, driven by the demand for functional foods, dietary supplements, and advanced pharmaceutical formulations. The region's strong research and development capabilities and technological advancements in biotechnology also contribute to its leading position in the D-amino acid market.
The Asia Pacific region is projected to witness the highest CAGR in the D-amino acid market during the forecast period. The region's growth can be attributed to factors such as rising disposable incomes, changing dietary preferences, and increasing health consciousness among consumers. Countries like China, Japan, and India are major contributors to the market's growth, driven by their large populations, expanding food and feed industries, and growing demand for nutritional supplements. The region's increasing investments in research and development, coupled with the adoption of advanced biotechnology techniques, are expected to further fuel the rapid growth of the D-amino acid market in Asia Pacific.
Key players in the market
Some of the key players in D-Amino Acid Market include Ajinomoto Co., Inc., Evonik Industries AG, Sigma-Aldrich (Merck KGaA), Kyowa Hakko Bio Co., Ltd., Thermo Fisher Scientific Inc., Central Drug House (P) Ltd., Amino GmbH, TCI Chemicals (India) Pvt. Ltd., Tokyo Chemical Industry Co., Ltd., PepTech Corporation, Wuhan Amino Acid Bio-Chemical Co., Ltd., Chemical Dynamics Corporation, AnaSpec, Inc., LifeSpan BioSciences, Inc., CBL Biotech Pvt. Ltd., Enzo Life Sciences, Inc., Bio-Synthesis Inc., Zhejiang NHU Company Ltd., Santa Cruz Biotechnology, Inc., and Creative Peptides.
In April 2024, Merck, a leading science and technology company, has launched the first all-in-one, validated genetic stability assay of its kind. The Aptegra(TM) CHO genetic stability assay leverages whole genome sequencing and bioinformatics to significantly accelerate biosafety testing for clients and therefore, their move into commercial production.
In January 2024, Qatar Free Zones Authority (QFZ) and Evonik, a leading specialty Chemicals Company headquartered in Germany, have signed a Memorandum of Understanding (MoU) at the sidelines of the Qatar Economic Forum. The common aim is to explore specific investment opportunities focused on sustainable solutions for energy transition.
In December 2023, Ajinomoto Co., Inc. announced that it completed procedures on December 21, 2023 (local time) for acquisition of all equities of Forge Biologics Holdings, LLC ("Forge") through its consolidated subsidiary Ajinomoto North America Holdings, Inc., in line with its press release "Ajinomoto Group Acquires Forge Biologics, a US-Based Gene Therapy CDMO for Approximately JPY 82.8 Billion".
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.